The interaction of hepatoma-derived growth factor and beta-catenin promotes tumorigenesis of synovial sarcoma
The interaction of hepatoma-derived growth factor and beta-catenin promotes tumorigenesis of synovial sarcoma
复制标题
肝癌源性生长因子与β-catenin的相互作用促进滑膜肉瘤的发生
DOI:
10.1007/s13277-016-4905-5
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Han Anjia
中科院分区:
文献类型:
--
作者:
Tang Jianming;Shi Huijuan;Li Hui;Zhen Tiantian;Dong Yu;Zhang Fenfen;Yang Yang;Han Anjia
To clarify the clinicopathological and biological role of hepatoma-derived growth factor (HDGF) and β-catenin in synovial sarcoma. Our results showed that histological type and HDGF/β-catenin expression were the two important independent prognostic factors for overall survival in synovial sarcoma patients. HDGF knockdown dramatically inhibited cellular proliferation, colony formation, and migration but induced G1 phase arrest and apoptosis in SW982 cells. Recombinant HDGF enhanced synovial sarcoma cell growth and partially retrieved the cell growth suppression in SW982 cells upon HDGF knockdown. HDGF knockdown dramatically suppressed β-catenin and its downstream gene expression in SW982 cells. Intriguingly, β-catenin knockdown dramatically suppressed HDGF expression in SW982 cells. A direct interaction of HDGF and β-catenin was found in SW982 cells. Three HDGF-binding elements in β-catenin promoter were found and specific for transcriptional activation of β-catenin in SW982 cells. In conclusion, our findings first indicate that the interaction of HDGF and β-catenin may play a crucial role in tumorigenesis of synovial sarcoma.